{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:29:28Z","timestamp":1790152168400,"version":"4.0.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1741,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1038\/mt.2011.214","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T15:53:34Z","timestamp":1318953214000},"page":"21-27","source":"Crossref","is-referenced-by-count":49,"title":["Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice"],"prefix":"10.1016","volume":"20","author":[{"given":"Kai","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darin J","family":"Falk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J","family":"Reier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David D","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.214_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2011.214_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1038\/mt.2011.214_bib3","series-title":"Metabolic Basis of Inherited Disease","first-page":"3389","article-title":"Glycogen storage disease type II: acid alpha-glucosidase (acid maltase) deficiency","author":"Hirschhorn","year":"2000"},{"key":"10.1038\/mt.2011.214_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr Mol Med"},{"key":"10.1038\/mt.2011.214_bib5","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.214_bib6","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00005072-197107000-00008","article-title":"Nervous system in Pompe's disease. Ultrastructure and biochemistry","volume":"30","author":"Gambetti","year":"1971","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/00005072-196501000-00008","article-title":"Pompe's disease (diffuse glycogenosis) with neuronal storage","volume":"24","author":"Mancall","year":"1965","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib8","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00687878","article-title":"Pompe's disease: an inborn lysosomal disorder with storage of glycogen. A study of brain and striated muscle","volume":"23","author":"Martin","year":"1973","journal-title":"Acta Neuropathol"},{"key":"10.1038\/mt.2011.214_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.57.5.906","article-title":"Intractable fever and cortical neuronal glycogen storage in glycogenosis type 2","volume":"57","author":"Martini","year":"2001","journal-title":"Neurology"},{"key":"10.1038\/mt.2011.214_bib10","first-page":"379","article-title":"Infantile-onset glycogen storage disease type II (Pompe disease): report of a case with genetic diagnosis and pathological findings","volume":"27","author":"Teng","year":"2004","journal-title":"Chang Gung Med J"},{"key":"10.1038\/mt.2011.214_bib11","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/030098588302000307","article-title":"Generalized glycogen storage disease in Japanese quail (Coturnix coturnix japonica)","volume":"20","author":"Matsui","year":"1983","journal-title":"Vet Pathol"},{"key":"10.1038\/mt.2011.214_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3476(50)80174-9","article-title":"Glycogen disease resembling mongolism, cretinism, and amytonia congenita; case report and review of literature","volume":"36","author":"Clement","year":"1950","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2011.214_bib14","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1212\/WNL.19.9.894","article-title":"Pompe's disease","volume":"19","author":"Hogan","year":"1969","journal-title":"Neurology"},{"key":"10.1038\/mt.2011.214_bib15","first-page":"1388","article-title":"[Three hypotonic neonates with hypertrophic cardiomyopathy: Pompe's disease]","volume":"142","author":"Willemsen","year":"1998","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1038\/mt.2011.214_bib16","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.15.6.715","article-title":"Glycogen disease of skeletal muscle; report of two cases and review of literature","volume":"15","author":"Zellweger","year":"1955","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2011.214_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2010.02.006","article-title":"Acute progression of neuromuscular findings in infantile Pompe disease","volume":"42","author":"Burrow","year":"2010","journal-title":"Pediatr Neurol"},{"key":"10.1038\/mt.2011.214_bib18","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","article-title":"CRIM-negative infantile Pompe disease: 42-month treatment outcome","volume":"33","author":"Rohrbach","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2011.214_bib19","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2011.214_bib20","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.214_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2011.214_bib22","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00455-009-9252-x","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","volume":"25","author":"Jones","year":"2010","journal-title":"Dysphagia"},{"key":"10.1038\/mt.2011.214_bib23","first-page":"147","article-title":"Language and speech function in children with infantile Pompe disease","volume":"7","author":"Muller","year":"2009","journal-title":"J Pediatr Neurol"},{"key":"10.1038\/mt.2011.214_bib24","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.expneurol.2010.08.026","article-title":"The phrenic motor nucleus in the adult mouse","volume":"226","author":"Qiu","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0006-8993(98)00169-3","article-title":"Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS","volume":"793","author":"Chamberlin","year":"1998","journal-title":"Brain Res"},{"key":"10.1038\/mt.2011.214_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/cne.21864","article-title":"Cervical prephrenic interneurons in the normal and lesioned spinal cord of the adult rat","volume":"511","author":"Lane","year":"2008","journal-title":"J Comp Neurol"},{"key":"10.1038\/mt.2011.214_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.expneurol.2010.08.026","article-title":"The phrenic motor nucleus in the adult mouse","volume":"226","author":"Qiu","year":"2010","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib29","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/0014-4886(68)90151-9","article-title":"A correlated histochemical and quantitative study on cerebral glycogen after brain injury in the rat","volume":"22","author":"Guth","year":"1968","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2011.214_bib30","series-title":"Physiology of Respiration","first-page":"65","author":"Hlastala","year":"2001"},{"key":"10.1038\/mt.2011.214_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.gt.3300358","article-title":"Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters","volume":"4","author":"Peel","year":"1997","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.214_bib32","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib33","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/mt.2009.305","article-title":"Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease","volume":"18","author":"Mah","year":"2010","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00115-005-2005-7","article-title":"[Glycogenesis Type II (M. Pompe). Selective failure of the respiratory musculature\u2013a rare first symptom]","volume":"77","author":"Burghaus","year":"2006","journal-title":"Nervenarzt"},{"key":"10.1038\/mt.2011.214_bib35","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe's disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"issue":"5 Pt 1","key":"10.1038\/mt.2011.214_bib36","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1006\/mthe.2002.0580","article-title":"Correction of the enzymatic and functional deficits in a model of Pompe disease using adeno-associated virus vectors","volume":"5","author":"Fraites","year":"2002","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib37","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1242\/dev.01169","article-title":"Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: Pompe disease","volume":"131","author":"Rucker","year":"2004","journal-title":"Development"},{"issue":"suppl. 5","key":"10.1038\/mt.2011.214_bib38","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","article-title":"Pompe disease in infants and children","volume":"144","author":"Kishnani","year":"2004","journal-title":"J Pediatr"},{"key":"10.1038\/mt.2011.214_bib39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.mt.6300100","article-title":"Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors","volume":"15","author":"Mah","year":"2007","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10545-010-9209-0","article-title":"CRIM-negative infantile Pompe disease: 42-month treatment outcome","volume":"33","author":"Rohrbach","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1038\/mt.2011.214_bib41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2011.00031","article-title":"Hypoglossal neuropathology and respiratory activity in pompe mice","volume":"2","author":"Lee","year":"2011","journal-title":"Front Physiol"},{"key":"10.1038\/mt.2011.214_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.ymthe.2006.05.005","article-title":"Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC","volume":"14","author":"Bankiewicz","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ymthe.2005.11.009","article-title":"Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders","volume":"13","author":"Mandel","year":"2006","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.214_bib44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/iub.284","article-title":"Therapy for lysosomal storage disorders","volume":"62","author":"Beck","year":"2010","journal-title":"IUBMB Life"},{"key":"10.1038\/mt.2011.214_bib45","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2011.214_bib46","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00246-008-9267-3","article-title":"Cardiac remodeling after enzyme replacement therapy with acid alpha-glucosidase for infants with Pompe disease","volume":"29","author":"Levine","year":"2008","journal-title":"Pediatr Cardiol"},{"key":"10.1038\/mt.2011.214_bib47","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00415-009-5367-0","article-title":"Use of the muscle volume analyzer to evaluate enzyme replacement therapy in late-onset Pompe disease","volume":"257","author":"Sugai","year":"2010","journal-title":"J Neurol"},{"key":"10.1038\/mt.2011.214_bib48","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1046-2023(02)00220-7","article-title":"Production and purification of serotype 1, 2, and 5 recombinant adeno-associated viral vectors","volume":"28","author":"Zolotukhin","year":"2002","journal-title":"Methods"},{"key":"10.1038\/mt.2011.214_bib49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1542\/peds.16.1.81","article-title":"A barometric method for measuring ventilation in newborn infants","volume":"16","author":"Drorbaugh","year":"1955","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2011.214_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1095-6433(98)10170-8","article-title":"The use of percentages and size-specific indices to normalize physiological data for variation in body size: wasted time, wasted effort?","volume":"122","author":"Packard","year":"1999","journal-title":"Comp Biochem Physiol A Mol Integr Physiol"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616304464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,13]],"date-time":"2024-04-13T21:00:39Z","timestamp":1713042039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616304464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S1525001616304464"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.214","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}